Multiple myeloma patients are better equipped to halt progression of this blood cancer if treated with lenalidomide, or Revlimid®, following a stem cell transplant.

PALO ALTO, Calif., May 15, 2012 /PRNewswire/ -- Telik, Inc. (Nasdaq: TELK) today announced two publications in the Journal of Hematology & Oncology.

Equity Research for the following companies: Electronic Arts (NASDAQ:EA), Celgene (NASDAQ:CELG), QUALCOMM (NASDAQ:QCOM), Monster Worldwide (NYSE:MWW), MetroPCS (NYSE:PCS), and Chevron (NYSE:CVX).

WHITE PLAINS, N.Y., April 26, 2012 /PRNewswire/ -- Thanks to funding from The Leukemia & Lymphoma Society (LLS), Epizyme has been advancing DOT1L,

NEW YORK, April 16, 2012 /PRNewswire/ -- The CementBloc was awarded Silver Awards for Best Integrated Campaign and Best Disease Education Campaign at the annual DTC National Advertising Awards